Back to funds
View filing
Venrock Adviser, LLC
Updated 6 days agoManaged by Venrock Adviser, Llc • Latest filing Q3 2026
Portfolio value
$2.1B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $2B |
| Q1 2026 | $2.7B |
| Q2 2026 | $3.3B |
| Q3 2026 | $2.1B |
Top holdings
34 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $345.5M | 4.15M | 16.79% | — | |
| 2 | $294.5M | 20.09M | 14.31% | — | |
| 3 | $221.3M | 2.49M | 10.75% | — | |
| 4 | $145.6M | 4.55M | 7.07% | — | |
| 5 | $101M | 19.57M | 4.91% | — | |
| 6 | $79.4M | 10.35M | 3.86% | — | |
| 7 | ? N/A DAMORA THERAPEUTICS INC | $76.7M | 3.60M | 3.73% | — |
| 8 | $72.4M | 822.0K | 3.52% | — | |
| 9 | $67.1M | 3.26M | 3.26% | — | |
| 10 | $58M | 3.04M | 2.82% | — | |
| 11 | $52.6M | 1.64M | 2.55% | — | |
| 12 | $51.4M | 3.21M | 2.50% | — | |
| 13 | $45.2M | 3.22M | 2.20% | — | |
| 14 | $44.5M | 5.50M | 2.16% | — | |
| 15 | $42M | 1.55M | 2.04% | — | |
| 16 | $39.7M | 2.94M | 1.93% | — | |
| 17 | $35M | 2.17M | 1.70% | — | |
| 18 | $32.4M | 1.63M | 1.58% | — | |
| 19 | $31.1M | 2.13M | 1.51% | — | |
| 20 | $28.1M | 7.45M | 1.36% | — |